Your browser doesn't support javascript.
loading
A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life.
Gaspard, Ulysse; Taziaux, Mélanie; Jost, Maud; Coelingh Bennink, Herjan J T; Utian, Wulf H; Lobo, Rogerio A; Foidart, Jean-Michel.
Affiliation
  • Gaspard U; From the Department of Obstetrics and Gynecology, University of Liège, Liège, Belgium.
  • Taziaux M; Estetra SRL, Mithra Pharmaceuticals, Liège, Belgium.
  • Jost M; Estetra SRL, Mithra Pharmaceuticals, Liège, Belgium.
  • Coelingh Bennink HJT; Pantarhei Bioscience, Zeist, the Netherlands.
  • Utian WH; Case Western Reserve University School of Medicine, Cleveland, OH.
  • Lobo RA; Columbia University Medical Center, New York, NY.
Menopause ; 30(5): 480-489, 2023 05 01.
Article in En | MEDLINE | ID: mdl-36809193
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaginal Diseases / Estetrol Type of study: Clinical_trials Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Menopause Journal subject: GINECOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaginal Diseases / Estetrol Type of study: Clinical_trials Aspects: Patient_preference Limits: Female / Humans Language: En Journal: Menopause Journal subject: GINECOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: